Delivery Order SPE2DB20D1109-SPE2DB23FP21D
- Not listed
- This federal contract award, valued at $2,659.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion (60 count), a specialty pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
- This is a Delivery Order valued at $7,949.34 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a period of performance through June 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award, valued at $2,533.77, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
- This federal contract award, valued at $1,044.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of cyclosporine 0.05% eye emulsion, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty medication, with a ceiling value of $1,088.96 and a period of performance through February 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for $7,424.52 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999, which serves as a primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
- This federal contract award, valued at $3,635.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Cyclosporine 0.05% Eye Emulsion, a specialty medication, and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, valued at $9,536.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CYCLOSPORINE 0.05% EYE EMULS 30S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November...
- This federal contract award, valued at $2,408.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty medication, to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,718.37 firm fixed-price delivery order is for the supply of CYCLOSPORINE 0.05% EYE EMULS 30S, a specialty medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP21DDelivery Order
This federal contract award, valued at $2,506.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty medication, to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the military globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 5/25/23 |